ASCO 2019 through art

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

This year, we decided to approach the annual meeting of the American Society of Clinical Oncology in a completely new way: through illustrations.

Our illustrator Katie Goldberg offered to go out into the crowded hallways and capture the images of ASCO 2019.

I have never thought of ASCO as fodder for art. When 40,000 people who share interests convene in one spot, they create a culture. When they meet for just a few days, they create an ephemeral culture.

Abstracts, photos, and videos capture that culture, but an artist can see something else: the energy of interactions, scenes you might simply rush past.

Katie and I agreed on the parameters of the assignment. Her goal wasn’t to capture images of important people as they delivered lectures or rushed by. Instead, she was to roam the halls, capturing something only an artist can see—the spirit of the gathering, its visual language, its motion.

We’ve interspersed her art throughout the pages of the our PDF issue, which you can download here, or scroll down to see the full gallery.

1 lead image
4 genentech cookies
5 pazdur
7 asco posters
9 overall shot
3 asco tv
2 asco fountain
6 checkpoints3
8 child-care
10 daily-news
11 pres-address
Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

The nagging pain in Mia Sandino’s right knee set in in September 2018, and throughout her freshman year at the University of Washington, she tried to ignore it. “I was being a very naive and invincible-feeling 19-year-old,” Sandino told The Cancer Letter. “I didn’t put two and two together that this area of the knee that...

Rick Pazdur, MD, the newly appointed director for the Center for Drug Evaluation and Research at the FDA, has been described as “greyhound thin” as a result of his dedication to cycling and lifting weights in the gym each day and, for a long time, a vegetarian diet. I first met him when he was the director of the Office of Oncology Drug Products (ODP) within CDER, in 2009.
When it comes to fighting cancer today, collaboration is key. At a time when funding is uncertain, yet innovative breakthroughs are accelerating every day, it’s more important than ever for oncologists, scientists, academic researchers, and community physicians, to come together to share knowledge and gain insights about the forefront of cancer research.
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login